Description

Ethyl 2-[3-(4-Methoxystyryl)-6-Oxo-5,6-Dihydro-1(4H)-Pyridazinyl]Acetate is a high-purity synthetic organic compound belonging to the pyridazinone class, serving as a crucial advanced pharmaceutical intermediate. Its molecular structure, featuring a methoxystyryl moiety, makes it a valuable building block for the research and development of novel therapeutic agents. This compound is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of active pharmaceutical ingredients (APIs) and other bioactive molecules.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in therapeutic areas targeting inflammation or metabolic disorders.
• Chemical Research & Development: Used as a core scaffold in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to create more complex, functionalized molecules for biological screening.
• Academic Research: Serves as a reference standard or starting material in university and institutional labs studying heterocyclic chemistry and drug discovery pathways.
• Bioconjugation Probe Development: Potential use in creating labeled compounds for biochemical assays and diagnostic research due to its modifiable functional groups.

Basic Information

Product Name	Ethyl 2-[3-(4-Methoxystyryl)-6-Oxo-5,6-Dihydro-1(4H)-Pyridazinyl]Acetate
CAS No.	1164457-83-3
Molecular Formula	C19H22N2O4
Molecular Weight	342.39 g/mol
Synonyms	Ethyl 2-(3-[(E)-2-(4-methoxyphenyl)ethenyl]-6-oxo-1,4,5,6-tetrahydropyridazin-1-yl)acetate; 1-(2-Ethoxy-2-oxoethyl)-3-[(E)-2-(4-methoxyphenyl)ethenyl]-4,5-dihydro-1H-pyridazin-6-one; 3-(4-Methoxystyryl)-1-(carbethoxymethyl)-4,5-dihydro-6(1H)-pyridazinone; Ethyl [3-(4-methoxystyryl)-6-oxo-1,4,5,6-tetrahydropyridazin-1-yl]acetate; 1164457-83-3; UNII-7V8V1T4J4H
EINECS	Contact for details

Quality Control

Our Ethyl 2-[3-(4-Methoxystyryl)-6-Oxo-5,6-Dihydro-1(4H)-Pyridazinyl]Acetate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity (typically ≥95% by HPLC), identity confirmation, and impurity profile is provided with every shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Any single impurity ≤ 1.0%
Total Impurities	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.